Back to Search Start Over

Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control

Authors :
Zappe, Dion
Papst, Cheraz Cherif
Ferber, Philippe
Source :
Vascular Health and Risk Management
Publication Year :
2009
Publisher :
Dove Medical Press, 2009.

Abstract

Objective: Delays in achieving blood pressure (BP) control may increase morbidity and mortality in patients with hypertension. Thus, deciding which antihypertensive agent to use and at what dosage, in addition to determining when to initiate combination therapy and which agents to combine, is important for achieving BP control. Methods: This randomized, double-blind, 14-week study was conducted to compare the efficacy and tolerability of various doses of valsartan ± hydrochlorothiazide (HCTZ) versus amlodipine ± HCTZ for maximizing BP control in 1,285 patients with uncontrolled hypertension. Patients with stage 1 hypertension and naïve to antihypertensive therapy (33.9%) started valsartan 160 mg or amlodipine 5 mg. Treatment-naïve patients with stage 2 hypertension (13.5%) or those uncontrolled on current antihypertensive monotherapy (52.6%) started valsartan 160 mg/HCTZ 12.5 mg or amlodipine 10 mg. At weeks 4, 8, and 11, patients not achieving BP control were up-titrated (maximum: valsartan 320 mg/HCTZ 25 mg, amlodipine 10 mg/HCTZ 25 mg). Results: At study end, 78.8% of patients on valsartan ± HCTZ were controlled (BP

Details

Language :
English
ISSN :
11782048 and 11766344
Volume :
5
Database :
OpenAIRE
Journal :
Vascular Health and Risk Management
Accession number :
edsair.pmid..........e64a8d2be438c42778d866e371b05785